Your browser doesn't support javascript.
loading
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Sahaf, Bita; Pichavant, Mina; Lee, Brian H; Duault, Caroline; Thrash, Emily M; Davila, Melanie; Fernandez, Nicolas; Millerchip, Karen; Bentebibel, Salah-Eddine; Haymaker, Cara; Sigal, Natalia; Del Valle, Diane M; Ranasinghe, Srinika; Fayle, Sarah; Sanchez-Espiridion, Beatriz; Zhang, Jiexin; Bernatchez, Chantale; Wu, Catherine J; Wistuba, Ignacio I; Kim-Schulze, Seunghee; Gnjatic, Sacha; Bendall, Sean C; Song, Minkyung; Thurin, Magdalena; Lee, J Jack; Maecker, Holden T; Rahman, Adeeb.
  • Sahaf B; Stanford Cancer Institute, Stanford Medicine, Stanford University, California. bsahaf@stanford.edu.
  • Pichavant M; Stanford Institute for Immunity, Transplantation and Infection, Stanford Medicine, Stanford university, California.
  • Lee BH; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Duault C; Stanford Institute for Immunity, Transplantation and Infection, Stanford Medicine, Stanford university, California.
  • Thrash EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Davila M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Fernandez N; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Millerchip K; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bentebibel SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sigal N; Stanford Institute for Immunity, Transplantation and Infection, Stanford Medicine, Stanford university, California.
  • Del Valle DM; Human Immune Monitoring Center, Tisch Cancer Institute and the Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Ranasinghe S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fayle S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sanchez-Espiridion B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wistuba II; Harvard Medical School, Harvard University, Boston, Massachusetts.
  • Kim-Schulze S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Gnjatic S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bendall SC; Human Immune Monitoring Center, Tisch Cancer Institute and the Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Song M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Thurin M; Department of Pathology, Stanford Medicine, Stanford University, Stanford, California.
  • Lee JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Maecker HT; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Rahman A; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 27(18): 5062-5071, 2021 09 15.
Article en En | MEDLINE | ID: mdl-34266889
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucocitos Mononucleares / Biomarcadores de Tumor / Citometría de Flujo / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucocitos Mononucleares / Biomarcadores de Tumor / Citometría de Flujo / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article